July 15, 2020 EVOX THERAPEUTICS EXPANDS EXISTING EXOSOME PATENT PORTFOLIO WITH FURTHER GRANT COVERING EXOSOMES FOR RNA THERAPEUTICS
June 9, 2020 EVOX THERAPEUTICS ANNOUNCES A MULTI-TARGET RNA INTERFERENCE AND ANTISENSE RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH LILLY
August 7, 2019 EVOX THERAPEUTICS GRANTED KEY EXOSOME PATENTS COVERING RNA THERAPEUTICS AND TARGETED DRUG DELIVERY
May 9, 2019 EVOX THERAPEUTICS EXPANDS LEADERSHIP TEAM WITH THE APPOINTMENT OF TWO EXPERIENCED LIFE SCIENCES EXECUTIVES
December 10, 2018 EVOX THERAPEUTICS TO EXPAND ITS WORK ON CELL-TARGETED DELIVERY OF NUCLEIC ACID-BASED DRUGS
November 13, 2018 EVOX THERAPEUTICS WINS FUNDING FROM DUCHENNE UK TO EXPLORE EXOSOME-MEDIATED DELIVERY OF DYSTROPHIN
